News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
285,447 Results
Type
Article (15500)
Company Profile (301)
Press Release (269640)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80652)
Career Advice (165)
Deals (13454)
Drug Delivery (39)
Drug Development (51928)
Employer Resources (31)
FDA (5956)
Job Trends (5318)
News (147148)
Policy (10255)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (961)
Accelerated approval (19)
Adcomms (16)
Allergies (81)
Alliances (22040)
ALS (124)
Alzheimer's disease (1034)
Antibody-drug conjugate (ADC) (247)
Approvals (6148)
Artificial intelligence (266)
Autoimmune disease (112)
Automation (9)
Bankruptcy (106)
Best Places to Work (4707)
BIOSECURE Act (6)
Biosimilars (101)
Biotechnology (231)
Bladder cancer (110)
Brain cancer (47)
Breast cancer (350)
Cancer (3335)
Cardiovascular disease (237)
Career advice (150)
Career pathing (7)
CAR-T (219)
CDC (5)
Cell therapy (573)
Cervical cancer (15)
Clinical research (44741)
Collaboration (1163)
Company closure (2)
Compensation (592)
Complete response letters (40)
COVID-19 (1108)
CRISPR (86)
C-suite (551)
Cystic fibrosis (112)
Data (4427)
Denatured (15)
Depression (92)
Diabetes (255)
Diagnostics (1426)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (190)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (32049)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (52405)
Executive appointments (621)
FDA (7725)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (987)
Gene editing (182)
Generative AI (21)
Gene therapy (487)
GLP-1 (512)
Government (1195)
Grass and pollen (3)
Guidances (169)
Healthcare (6741)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (193)
Immuno-oncology (43)
Indications (68)
Infectious disease (1213)
Inflammatory bowel disease (157)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (168)
Interviews (19)
IPO (7406)
IRA (12)
Job creations (879)
Job search strategy (131)
JPM (40)
Kidney cancer (11)
Labor market (22)
Layoffs (255)
Leadership (9)
Legal (1409)
Liver cancer (53)
Longevity (11)
Lung cancer (470)
Lymphoma (259)
Machine learning (26)
Management (7)
Manufacturing (376)
MASH (130)
Medical device (2673)
Medtech (2682)
Mergers & acquisitions (6674)
Metabolic disorders (725)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (229)
Neuropsychiatric disorders (70)
Neuroscience (1953)
Neurotech (1)
NextGen: Class of 2026 (2066)
Non-profit (884)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (137)
Pain (102)
Pancreatic cancer (167)
Parkinson's disease (232)
Partnered (12)
Patents (306)
Patient recruitment (335)
Peanut (43)
People (26786)
Pharmaceutical (45)
Pharmacy benefit managers (7)
Phase 1 (15854)
Phase 2 (20761)
Phase 3 (13205)
Pipeline (3302)
Policy (90)
Postmarket research (859)
Preclinical (6681)
Press Release (30)
Prostate cancer (147)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (647)
Real estate (1455)
Recruiting (12)
Regulatory (10062)
Reports (19)
Research institute (1022)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (185)
Series B (135)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (18)
Startups (2015)
State (1)
Stomach cancer (8)
Supply chain (33)
Tariffs (18)
The Weekly (62)
Vaccines (347)
Venture capital (69)
Weight loss (174)
Women's health (26)
Worklife (2)
Date
Last 7 days (347)
Last 30 days (1224)
Last 365 days (18117)
2026 (1677)
2025 (18402)
2024 (20822)
2023 (22765)
2022 (27254)
2021 (28265)
2020 (23778)
2019 (16605)
2018 (11990)
2017 (14080)
2016 (12096)
2015 (14564)
2014 (10481)
2013 (7508)
2012 (7561)
2011 (7621)
2010 (7431)
Location
Africa (155)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18605)
Australia (3167)
California (7158)
Canada (1846)
China (787)
Colorado (248)
Connecticut (255)
Delaware (246)
Europe (39924)
Florida (924)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (412)
India (36)
Indiana (161)
Iowa (8)
Japan (228)
Kansas (81)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (757)
Massachusetts (5622)
Michigan (111)
Minnesota (247)
Mississippi (3)
Missouri (39)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (22)
New Jersey (1745)
New Mexico (13)
New York (1773)
North Carolina (829)
North Dakota (6)
Northern California (3507)
Ohio (178)
Oklahoma (11)
Oregon (24)
Pennsylvania (1278)
Puerto Rico (9)
Rhode Island (25)
South America (216)
South Carolina (9)
Southern California (2850)
Tennessee (42)
Texas (918)
United States (23680)
Utah (96)
Virginia (141)
Washington D.C. (37)
Washington State (598)
West Virginia (1)
Wisconsin (46)
285,447 Results for "checkpoint therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
December 4, 2025
·
8 min read
Cardiovascular disease
Deep Dive: Checkpoint Inhibitors at a Crossroads
A new generation of checkpoint inhibitors is emerging, with some showing more promise than others. From recent TIGIT failures to high-potential targets like VEGF,
BioSpace
explores what’s on the horizon in immuno-oncology.
May 19, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint Inhibitor for Patients with Metastatic Colorectal Cancer
February 2, 2026
·
7 min read
Press Releases
ImmunityBio Announces Positive Results Demonstrating ANKTIVA® as a Lymphocyte Stimulating Agent in Combination With Checkpoint Inhibitors in Non-Small Cell Lung Cancer
January 14, 2026
·
9 min read
Press Releases
Ankyra Therapeutics Announces First Patient Dosed in Phase 1b Trial Evaluating First-in-Class Anchored Immunotherapy in Combination with Immune Checkpoint Blockade in Patients with Lung Cancer
November 18, 2025
·
3 min read
Press Releases
Pilatus Biosciences Announces FDA Clearance of IND Application for PLT012, a First-in-Class Anti-CD36 Metabolic Checkpoint Antibody in Solid Tumors
December 16, 2025
·
4 min read
Press Releases
Akari Therapeutics Presents Promising Immuno-Oncology Data for its Novel Splicing-Targeted ADC Payload Driving Immune Activation, Both as Single Agent and in Combination with Anti-PD1 Checkpoint Inhibitors
November 11, 2025
·
10 min read
Press Releases
Sun Pharma Completes its Acquisition of Checkpoint Therapeutics
May 30, 2025
·
10 min read
Press Releases
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics
June 2, 2025
·
6 min read
Press Releases
Sun Pharma to Acquire Checkpoint Therapeutics
March 10, 2025
·
24 min read
1 of 28,545
Next
